Alpha 2.0
Login Register
» Journals » Diabetol Metab Syndr

Diabetology & Metabolic Syndrome

Diabetology & Metabolic Syndrome is a peer-reviewed journal dedicated to advancing knowledge and understanding of diabetes and metabolic disorders. It publishes high-quality research articles, reviews, and case reports that explore the pathophysiology, diagnosis, treatment, and prevention of these conditions. The journal aims to bridge the gap between basic science and clinical practice, providing valuable insights for healthcare professionals, researchers, and policymakers in the field of diabetology and metabolic syndrome.
Details
Abbr. Diabetol Metab Syndr
Publisher Biomed Central
Start 2009
End Continuing
e-ISSN 1758-5996
Country United Kingdom
Language English
Specialty Endocrinology
Metrics
h-index / Ranks: 5296 68
SJR / Ranks: 3030 1147
CiteScore / Ranks: 3145 6.70
JIF / Ranks: 1690 4.8
Recent Articles
1.
Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, Cameroon
Diesse J, Jadhav S, Tamekou S, Simo G, Dzoyem J, Souopgui J, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):86. PMID: 40089790
Background: This study investigates the gut microbiota components associated with metabolic syndrome in patients living with HIV-1 at Bafoussam Regional Hospital, West Cameroon, it focuses on gastrointestinal mucosal barrier disruption...
2.
U-shaped relationship of estimated glucose disposal rate with cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stages 0-3: a population-based prospective study
Liang X, Lai K, Li X, Gui S, Xing Z, Li Y
Diabetol Metab Syndr . 2025 Mar; 17(1):85. PMID: 40069902
Background: Cardiovascular-Kidney-Metabolic (CKM) syndrome is characterized by the interrelatedness of chronic kidney disease (CKD), cardiovascular disease (CVD), and metabolic disorders. The relationship between estimated glucose disposal rate (eGDR) and CVD...
3.
Recent advances in understanding the mechanisms by which sodium-glucose co-transporter type 2 inhibitors protect podocytes in diabetic nephropathy
Chen X, Wang M, Yan Z
Diabetol Metab Syndr . 2025 Mar; 17(1):84. PMID: 40051002
Background: Diabetes mellitus is associated with systemic damage across multiple organ systems, and an increasing number of patients are presenting with diabetic kidney disease as its initial manifestation. The onset...
4.
Association between metabolic visceral fat score and left ventricular hypertrophy in individuals with type 2 diabetes
Wang L, Liu S, Ke J, Cao B, Wang D, Zhao Q, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):81. PMID: 40050939
Background: Left ventricular hypertrophy (LVH), a hallmark of early-stage heart failure (HF), is a common complication in individuals with type 2 diabetes mellitus (T2DM). Metabolic Visceral Fat Score (METS-VF), a...
5.
GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome
Jagomae T, Velling S, Tikva T, Maksimtsuk V, Gaur N, Reimets R, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):82. PMID: 40050934
Background And Aim: Wolfram syndrome (WS) is a rare autosomal disorder caused by WFS1 gene mutations, currently lacking approved treatments. Preclinical and clinical reports suggest that diabetes medications, such as...
6.
Association of obesity and LDL subfractions evaluated by body mass index, waist circumference, and diabetes status: the ELSA-Brasil study
Moraes E, Generoso G, Bensenor I, Santos R, Santos I, Goulart A, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):83. PMID: 40050922
Low-density lipoproteins (LDL) comprise a pool of particles with different densities that may have variable impact on atherogenesis. Studies suggest that obese individuals with elevated body mass index (BMI) and...
7.
The causal effect of glaucoma and diabetic retinopathy: a Mendelian randomization study
Chen S, Lin M, Hong Y
Diabetol Metab Syndr . 2025 Mar; 17(1):80. PMID: 40045419
Background: Previous research showed that there is an important association between glaucoma and diabetic retinopathy (DR). However, the relationship has not been clarified. In this study, we attempted to evaluate...
8.
Association of triglyceride-glucose index with bone mineral density and fracture: a systematic review
Yousefiasl M, Soltanattar A, Ezzatollahi Tanha A, Azami P, Alaei M, Alamdari A, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):77. PMID: 40038837
Background And Aim: Studies have found inconsistent results regarding triglyceride-glucose (TyG) index and bone health. This systematic review aims to synthesize the existing evidence on the association between the (TyG)...
9.
Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study
Emara S, Fahmy S, AbdelSalam M, Wakeel L
Diabetol Metab Syndr . 2025 Mar; 17(1):79. PMID: 40038825
Background: Diabetic peripheral neuropathy (DPN) is a vastly common and bothersome disorder with a clinically challenging course of treatment affecting patients with diabetes. This study aimed to evaluate the efficacy...
10.
Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society
Rodacki M, Zajdenverg L, da Silva Junior W, Giacaglia L, Negrato C, Cobas R, et al.
Diabetol Metab Syndr . 2025 Mar; 17(1):78. PMID: 40038723
Background: Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals...